Is besifloxacin effective for the treatment of bacterial conjunctivitis?

Updated: Oct 22, 2018
  • Author: Michael A Silverman, MD, MD; Chief Editor: Barry E Brenner, MD, PhD, FACEP  more...
  • Print
Answer

Answer

The US Food and Drug Administration (FDA) approved a new drug, besifloxacin, for the treatment of bacterial conjunctivitis. [3] Clinical studies showed that patients randomized to besifloxacin ophthalmic suspension 0.6% experienced significantly higher rates of clinical resolution and microbial eradication than patients randomized to vehicle. Besifloxacin was found to be as effective and well tolerated as moxifloxacin ophthalmic solution 0.5%. [4] In addition, a study by Comstock et al also showed besifloxacin ophthalmic suspension 0.6% to be safe and effective for the treatment of bacterial conjunctivitis. [5]


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!